AKT1 and hepatocellular carcinoma: For instance, in hepatocellular carcinoma (HCC), SRSF1 can enhance KLF6 alternative splicing through the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway, generating three splice variants that expedite tumor progression and metastasis [38].